| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/03/2011 | WO2010117727A3 Phenserine and posiphen for treating neuropsychiatric and neurodegenerative conditions |
| 03/03/2011 | WO2010102991A3 Riluzole liquid emulsions |
| 03/03/2011 | WO2010102923A3 Riluzole aqueous suspensions |
| 03/03/2011 | WO2010036998A3 Indole and indoline derivatives and methods of use thereof |
| 03/03/2011 | WO2008065408A9 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 03/03/2011 | WO2008038155A3 Controlled-release pharmaceutical tablets |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054442 Cell Membrane Translocation of Regulated Snare Inhibitors, Compositions Therefor, and Methods for Treatment of Disease |
| 03/03/2011 | US20110054043 Film composition |
| 03/03/2011 | US20110054038 Cns pharmaceutical compositions and methods of use |
| 03/03/2011 | US20110054032 Dioxoanthracene sulphonate derivatives |
| 03/03/2011 | US20110054030 Use of eicosapentaenoic acid and/or docosahexahenoic acid in women with endometriosis |
| 03/03/2011 | US20110054029 Water-soluble dietary fatty acids |
| 03/03/2011 | US20110054025 Use of a pentacyclic triterpene in a pharmaceutical composition for the treatment of multiple sclerosis |
| 03/03/2011 | US20110054018 Inotilone derivatives as coherent biological response modifier (cBMR) |
| 03/03/2011 | US20110054014 Prenylflavanone compounds and uses thereof |
| 03/03/2011 | US20110054013 Tetrahydropyranochromene gamma secretase inhibitors |
| 03/03/2011 | US20110054005 Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same |
| 03/03/2011 | US20110053999 4-methylpyrazole formulations for inhibiting ethanol intolerance |
| 03/03/2011 | US20110053993 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 03/03/2011 | US20110053985 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2011 | US20110053984 Novel 4-benzhydryloxy-tetraalkyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/03/2011 | US20110053983 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 03/03/2011 | US20110053982 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053981 Methods and Compositions Using Cholinesterase Inhibitors |
| 03/03/2011 | US20110053980 Indane-amine derivatives, their preparation and use as medicaments |
| 03/03/2011 | US20110053979 Pyridine derivatives used to treat orexin related disorders |
| 03/03/2011 | US20110053978 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter |
| 03/03/2011 | US20110053973 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053971 Nalmefene di-ester prodrugs |
| 03/03/2011 | US20110053970 Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency |
| 03/03/2011 | US20110053962 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 03/03/2011 | US20110053960 Method for treating pain syndrome and other disorders |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053957 Malonate salt of 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same |
| 03/03/2011 | US20110053956 Treatment for Neurological and Mental Disorders |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053953 AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613 |
| 03/03/2011 | US20110053951 Methods for treating disorders using nmda nr2b-subtype selective antagonist |
| 03/03/2011 | US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053948 Pyrrolidines as nk3 receptor antagonists |
| 03/03/2011 | US20110053947 Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |
| 03/03/2011 | US20110053940 3,4-substituted piperidine derivatives as renin inhibitors |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053931 Quinoline compounds and methods of use |
| 03/03/2011 | US20110053925 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/03/2011 | US20110053922 Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists |
| 03/03/2011 | US20110053920 Substituted bicyclic pyrimidines |
| 03/03/2011 | US20110053918 Gamma secretase modulators |
| 03/03/2011 | US20110053917 Allosteric Modulators of the A1 Adenosine Receptor |
| 03/03/2011 | US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 03/03/2011 | US20110053904 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | US20110053897 Compounds and compositions as syk kinase inhibitors |
| 03/03/2011 | US20110053889 Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function |
| 03/03/2011 | US20110053876 macrolides and their use |
| 03/03/2011 | US20110053873 Hsp90 inhibitors |
| 03/03/2011 | US20110053866 Pharmaceutical compositions |
| 03/03/2011 | US20110053859 Methods to reduce the effects of sleep deprivation |
| 03/03/2011 | US20110053858 Heterocyclic peptide ketoamides |
| 03/03/2011 | US20110053857 Yeast cells expressing tar dna-binding protein 43 and uses therefor |
| 03/03/2011 | US20110053856 Metabolite derivatives of the hdac inhibitor fk228 |
| 03/03/2011 | US20110053844 Liquid formulation of g-csf conjugate |
| 03/03/2011 | US20110053840 Allele and isotope-specific intervention on mhc class ii molecules associated with autoimmune diseases by means of peptides |
| 03/03/2011 | US20110053833 Synthetic peptides and their use |
| 03/03/2011 | US20110053827 Intranasal administration |
| 03/03/2011 | US20110053217 Polynucleotides encoding signal peptide-containing molecules |
| 03/03/2011 | US20110052737 Topical skin formulations comprising botanical extracts |
| 03/03/2011 | US20110052729 Pharmaceutical or nutraceutical composition |
| 03/03/2011 | US20110052723 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 03/03/2011 | US20110052713 Repairing damaged nervous system tissue with nanoparticles |
| 03/03/2011 | US20110052694 Use of cannabidiol prodrugs in topical and transdermal administration with microneedles |
| 03/03/2011 | US20110052687 Extended release pharmaceutical composition of paliperidone |
| 03/03/2011 | US20110052684 Pharmaceutical composition |
| 03/03/2011 | US20110052681 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 03/03/2011 | US20110052674 Angiotensin ii receptor blocker derivatives |
| 03/03/2011 | US20110052666 Compositions, Methods, and Systems for SIRNA Delivery |
| 03/03/2011 | US20110052658 Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration |
| 03/03/2011 | US20110052648 Oral modified-release formulations containing thiazepines |
| 03/03/2011 | US20110052647 Antidepressant Oral Pharmaceutical Compositions |
| 03/03/2011 | US20110052643 Compounds for inflammation and immune-related uses |
| 03/03/2011 | US20110052623 Dried microbial cells or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine and method for production of the dried microorganism cell or microorganism extract |
| 03/03/2011 | US20110052621 Pcsk9 vaccine |
| 03/03/2011 | US20110052613 Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase |
| 03/03/2011 | US20110052612 Spiropiperidine compound and medicinal use thereof |
| 03/03/2011 | US20110052611 Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease |
| 03/03/2011 | US20110052566 Cognitive function |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110052556 Pharmaceutical composition comprising racetam and carnitine and process for its preparation |
| 03/03/2011 | US20110052552 Compositions to effect neuronal growth |
| 03/03/2011 | US20110052549 Cell culture device to differentiate stem cells in a specific orientation |
| 03/03/2011 | US20110052548 Cell culture media to differentiate embryonic stem cells into neuronal lineages |
| 03/03/2011 | US20110052546 Inhibition of SHIP to Enhance Stem Cell Harvest and Transplantation |
| 03/03/2011 | US20110052535 Compositions for treating an inflammatory autoimmune condition |
| 03/03/2011 | US20110052531 Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy |
| 03/03/2011 | US20110052528 Neuroprotective macrocyclic compounds and methods for their use |
| 03/03/2011 | US20110052527 Imidazopyridinyl thiazolyl histone deacetylase inhibitors |
| 03/03/2011 | US20110052501 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |